Literature DB >> 22484101

A novel splint for proximal interphalangeal joint contractures: a case report.

Ronit Wollstein1, John Rodgers, Thomas Ogden, Jacqueline Loeffler, Jonathan Pearlman.   

Abstract

Proximal interphalangeal (PIP) joint contractures are notoriously difficult to treat. Best results are obtained with early mobilization and splinting, though a high level of adherence is critical for a good outcome. A new roll-on splint that aims to increase motion with minimal difficulty was used. The patient described here with moderate PIP joint contractures (30°-60°) was treated successfully using this splint. The splint design and therapy protocol are described. The patient was treated for 12 weeks with good adherence to therapy and splinting. Total active motion increased by 87% in the index finger and 108% in the ring finger. Grip, pinch, and tip-pinch strengths increased. The Disabilities of the Arm, Shoulder and Hand score improved from 26.7% to 2.5%. At 3 months, the patient returned to work. Though this case illustrates some of the advantages and disadvantages of the new splint, further study is necessary to evaluate the splint and compare it with other existing forms of treatment for PIP joint contractures.
Copyright © 2012 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22484101     DOI: 10.1016/j.apmr.2012.03.028

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  2 in total

Review 1.  Orthotic management of fixed flexion deformity of the proximal interphalangeal joint following traumatic injury: A systematic review.

Authors:  Nicole Young; Nichola Terrington; Diana Francis; Luke S Robinson
Journal:  Hong Kong J Occup Ther       Date:  2018-03-27       Impact factor: 0.917

2.  Methods for assessment of patient adherence to removable orthoses used after surgery or trauma to the appendicular skeleton: a systematic review.

Authors:  Gareth Davies; Daniel Yeomans; Zoe Tolkien; Irene A Kreis; Shelley Potter; Matthew D Gardiner; Abhilash Jain; James Henderson; Jane M Blazeby
Journal:  Trials       Date:  2020-06-08       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.